血液疾患に合併した発熱性好中球減少症に対するmeropenem 1g1日3回投与の臨床的有用性

Material type: 文書・図像類

Author: 池ヶ谷, 諭史ほか

Publisher: -

Publication date: 2012-09

Material Format: Digital

Capacity, size, etc.: -

NDC: -

View All

Notes on use

Note (General)：: BACKGROUND: Febrile neutropenia (FN) is a very important cause of mortality in patients receiving intensive chemotherapy. In 2010 meropenem (MEPM) 3g ...

Search by Bookstore

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

List of Cooperating Institutions and Databases

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

Ｕｎｉｖｅｒｓｉｔｙ　ｏｆ　Ｆｕｋｕｉ　Ａｃａｄｅｍｉｃ　Ｒｅｐｏｓｉｔｏｒｙ
Digital
You can check the holdings of institutions and databases with which 学術機関リポジトリデータベース（IRDB）（機関リポジトリ） is linked at the site of 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）.
Ｕｎｉｖｅｒｓｉｔｙ　ｏｆ　Ｆｕｋｕｉ　Ａｃａｄｅｍｉｃ　Ｒｅｐｏｓｉｔｏｒｙ

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type: 文書・図像類
Title: 血液疾患に合併した発熱性好中球減少症に対するmeropenem 1g1日3回投与の臨床的有用性
Author/Editor: 池ヶ谷, 諭史
岩崎, 博道
李, 心
高井, 美穂子
細野, 奈穂子
岸, 愼治
山内, 高弘
吉田, 明
浦崎, 芳正
上田, 孝典
Author Heading: 池ヶ谷, 諭史
岩崎, 博道
李, 心
高井, 美穂子
細野, 奈穂子
岸, 愼治
山内, 高弘
吉田, 明
浦崎, 芳正
上田, 孝典
Publication Date: 2012-09
Publication Date (W3CDTF): 2012-09
Periodical title: 日本化学療法学会雑誌
No. or year of volume/issue: 60 5
Volume: 60
Issue: 5
Pages: 549-552
Text Language Code: jpn
Subject Heading: febrile neutropenia
meropenem
empiric therapy
Target Audience: 一般
Note (General): BACKGROUND: Febrile neutropenia (FN) is a very important cause of mortality in patients receiving intensive chemotherapy. In 2010 meropenem (MEPM) 3g per day was approved for the treatment of FN in Japan, however, there are not enough reports about 3g usage of MEPM in Japanese patients yet. OBJECTIVE: This study assessed the clinical efficacy and safety of MEPM 1g three times a day as empirical monotherapy for FN in hematological patients. METHODS: This is the retrospective cohort study involved inpatients at Fukui university hospital. Fifty-six patients received 3g MEPM from January 2010 to January 2011. The mean age was 64.2. The underlying diseases were acute leukemia in 33 cases, malignant lymphoma in 15 and myelodysplastic syndrome in 8. RESULTS: The response rate was 80% (excellent response: 62%, good response: 18%, minor response: 16%, no response: 4%). The febrile duration was average 4.18 days. Treatment did not need to be discontinued or interrupted due to adverse events in any of the patients. CONCLUSIONS: This study suggests that MEPM 1g three times per day is useful and tolerable therapy in Japanese FN patients.
Source: https://u-fukui.repo.nii.ac.jp/?action=repository_action_common_download&item_id=20217&item_no=1&attribute_id=22&file_no=1
https://u-fukui.repo.nii.ac.jp/?action=repository_action_common_download&item_id=20217&item_no=1&attribute_id=22&file_no=1
Access Restrictions: 限定公開
Data Provider (Database): 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）
https://irdb.nii.ac.jp
Original Data Provider (Database): 福井大学 : 福井大学学術機関リポジトリ